Trial intelligence / Profile preview

Ambroxol Inhalation for Lower Respiratory Tract Infection Phlegm Symptoms

ChiCTR-IIR-16009810Phase 4Not yet recruiting

Sponsor
Peking University Third Hospital
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in pulmonary infection comparing Ambroxol inhalation with Placebo inhalation (2 arms). Primary endpoints: Sputum score, Expectoration difficulty score and 2 more. Planned start Dec 2016; status: not yet recruiting.

02

Drugs

ambroxol
03

Conditions

pulmonary infection

Beyond the preview

Go deeper on ChiCTR-IIR-16009810.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-16009810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call